Results 131 to 140 of about 1,691 (152)

Acceptability of a proposed practice pharmacist-led review for opioid-treated patients with persistent pain: A qualitative study to inform intervention development. [PDF]

open access: yesBr J Pain
Cornwall N   +13 more
europepmc   +1 more source

Targeting colorectal cancer at the level of nuclear pore complex. [PDF]

open access: yesJ Adv Res
Khakwani MMAK   +5 more
europepmc   +1 more source

Systematic identification of 20S proteasome substrates. [PDF]

open access: yesMol Syst Biol
Pepelnjak M   +7 more
europepmc   +1 more source

Ethylene oligomerisation chromium catalysts with unsymmetrical PCNP ligands

open access: yesDalton Transactions, 2021
PCNP diphosphines, in conjunction with Cr(acac)3, are excellent ethylene oligomerisation catalysts with high activity and selectivity towards both 1-hexene and 1-octene formation.
Mark R J Elsegood, Martin B Smith
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

PCNP: A new era in shaping health policy

Journal of the American Association of Nurse Practitioners, 2020
ABSTRACT The Pennsylvania Coalition of Nurse Practitioners (PCNP) is the state organization that promotes and protects the practice of more than 15,000 certified registered nurse practitioners in Pennsylvania. PCNP, credited for many legislative successes related to nurse practitioner (NP) practice since the 1980s, continues to expand its ...
Adele Marie, Caruso, Cheryl, Schlamb
openaire   +2 more sources

The PCNP/β-Catenin Axis Promotes Ovarian Cancer Progression

SSRN Electronic Journal, 2019
PCNP is associated with human cancers including neuroblastoma and lung cancer. However, the role and underlying molecular mechanism of PCNP have not been plenty elucidated. Herein, we first investigated the effects of PCNP in ovarian cancer proliferation, apoptosis, migration and invasion and determined the molecular mechanism of PCNP in ovarian cancer
Pengzhen Dong   +8 more
openaire   +1 more source

Small‐Sized Cationic miRi‐PCNPs Selectively Target the Kidneys for High‐Efficiency Antifibrosis Treatment

Advanced Healthcare Materials, 2018
AbstractSmall‐sized cationic miRi (microRNA‐21 inhibitor)‐PCNPs (low molecular weight chitosan (LMWC)‐modified polylactide‐co‐glycoside (PLGA) nanoparticles (PLNPs)) with special kidney‐targeting and high‐efficiency antifibrosis treatment are fabricated through coupling miRi, PLGA, and LMWC.
Xinran Geng   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy